Agastiya Biotech ^Private

Agastiya Biotech is a new drug development company based in Temecula, California. They specialize in delivering innovative pharmaceutical products to the marketplace, with a focus on areas where there is a high unmet medical need. The company has developed several novel small molecules with patents for different types of cancer, including leukemia and pancreatic cancer. Their pipeline includes breakthrough therapies in cancer stem cells, tumor suppressor genes, and oncogene mutations. Recently, their small molecule AB001 has shown promising results in Phase 1 studies for multiple metastatic solid tumors, and has received Orphan Drug Designations for glioblastoma, pancreatic cancer, and acute myeloid leukemia indications.